In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products
This study aims to assess the in vitro activity of different samples of cefoperazone/sulbactam (CFP/SUL) against multidrug-resistant organisms (MDROs). Clinical isolates of extended-spectrum β-lactamase (ESBL)-<i>Escherichia coli</i>, ESBL-<i>Klebsiella pneumoniae</i>...
Main Authors: | Ming-Jen Sheu, Chi-Chung Chen, Ying-Chen Lu, Bo-An Su, Chun-Cheng Zhang, Shu-Shen Wang, Yin-Ching Chuang, Hung-Jen Tang, Chih-Cheng Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/9/2/77 |
Similar Items
-
Antimicrobial activities of cefoperazone-sulbactam in comparison to cefoperazone against clinical organisms from medical centers in Taiwan
by: Tsung-Ta Chiang, et al.
Published: (2016-01-01) -
Coagulopathy Induced by Cefoperazone/Sulbactam in a Geriatric Patient
by: Ergenekon Karagoz, et al.
Published: (2015-12-01) -
In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
by: Lai CC, et al.
Published: (2018-12-01) -
Appropriate composites of cefoperazone–sulbactam against multidrug-resistant organisms
by: Lai CC, et al.
Published: (2018-09-01) -
Comparison of Tigecycline or Cefoperazone/Sulbactam therapy for bloodstream infection due to Carbapenem-resistant Acinetobacter baumannii
by: Tianshui Niu, et al.
Published: (2019-03-01)